This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...
Tag: BIIB
Dow ends over 700 points higher to exit bear market after Powell signals smaller interest-rate hikes ahead
U.S. stocks finished sharply higher on Wednesday, with the Dow Jones Industrial Average rising over 700 points to technically exit a bear market, after Federal Reserve Chairman Powell said the central...
An Alzheimer’s Drug’s Big Surprise: What It Means
Until this past week, there seemed to be no answers to the Alzheimer’s puzzle. The leading theory of the disease, that it was caused by a buildup of beta amyloid plaque in the brain, had been disprove...
As Time Passes, and the Weather Warms, Putin’s Power Play in Europe Loses Force
Why isn’t Putin’s move to cut off natural-gas shipments to Poland and Bulgaria causing a bigger spike in prices? Elias Stein Text size Vladimir Putin’s move to cut off natural-gas shipments to Poland ...
Biogen’s stock falls 3.7% after announcing earnings, says it brought in $1 million in sales of Alzheimer’s drug in the fourth quarter
An earlier version of this report had the wrong consensus and revenue numbers. It has been corrected. Shares of Biogen Inc. BIIB, -1.92% were down 3.7% in premarket trading on Thursday after the compa...
Biogen’s Alzheimer’s Drug Aduhelm Has Another Shot at Success
Illustration by Elias Stein Text size Biogen ’s Alzheimer’s disease therapy, Aduhelm, has been a disappointment for the company since its Food and Drug Administration approval last spring, with early ...
Biogen Stock Has Fallen 50%. Why It’s Time to Buy.
Text size Biogen’s Alzheimer’s disease treatment was once expected to be a megablockbuster. Dominick Reuter/AFP via Getty Images Shares of the biotech firm Biogen are down 50% since June 1...